This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Pharma Clinical Trial Services: World Market 2013-2023

9.1.2 The Importance of the European Market

9.1.3 Expansion to Meet Demand

9.1.4 The Role of Small and Medium-Sized CROs in the Market

9.1.5 Technological Developments to Benefit Clinical Trials 2013-2023

9.1.6 Trends Affecting Clinical Trial Outsourcing 2013-2023

9.2 Dr Vladimir Bogin, President and CEO, Cromos Pharma

9.2.1 Cromos Pharma

9.2.2 The Advantages of Regional Specialisation

9.2.3 Considerations for Conducting Trials in the CEE Region

9.2.4 Future Growth Opportunities in the CEE Region

9.2.5 Challenges for Conducting Trials in the CEE Region

10. Conclusions from Our Study

10.1 The State of the Clinical Trial Services Market10.1.1 A Market Dominated by the Developed Countries10.2 Strong Growth for the Overall Market 2013-202310.3 Which CROs Can Take Best Advantage of Market Growth in the Next 10 Years?10.3.1 The Role of Technology in the Future of Clinical Trial Services10.3.2 How Can CROs Specialise to Remain Competitive?

List of Tables

Table 1.1 Currency Exchange Rates, 2011

Table 2.1 Founding Members of the ICH

Table 2.2 Types of Adaptive Trial Design

Table 3.1 Breakdown of Pharma Clinical Spending by Phase

Table 3.2 Pharma Clinical Trial Services Market, 2008-2011

Table 3.3 Pharma Clinical Trial Services Market by Sector, 2011

Table 3.4 CRO Clinical Trial Services Revenue by Customer Type, 2011

Table 3.5 Pharma Clinical Trial Services Market: Overall Market and Revenue Forecasts by Sector, 2011-2023

Table 3.6 Clinical Trial Services Submarket Shares, 2011-2023

Table 3.7 Early Phase Clinical Trial Services Submarket Forecast, 2011-2023

Table 3.8 Late Phase Clinical Trial Services Submarket Forecast, 2011-2023

Table 4.1 World Pharma Clinical Trial Services Market by Region, 2011

Table 4.2 Pharma Clinical Trial Services Market: Revenue Forecasts by Country, 2011-2023

Table 4.3 Pharma Clinical Trial Services: Market Shares by Country, 2011-2023

Table 4.4 US Clinical Trial Services Market Forecast, 2011-2023

Table 4.5 Western European Clinical Trial Services Market by Country, 2011

7 of 13

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,678.23 -40.31 -0.23%
S&P 500 2,056.15 -4.90 -0.24%
NASDAQ 4,863.3620 -13.1570 -0.27%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs